393 related articles for article (PubMed ID: 25552417)
21. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
22. Expression of androgen receptor coregulators in prostate cancer.
Linja MJ; Porkka KP; Kang Z; Savinainen KJ; Jänne OA; Tammela TL; Vessella RL; Palvimo JJ; Visakorpi T
Clin Cancer Res; 2004 Feb; 10(3):1032-40. PubMed ID: 14871982
[TBL] [Abstract][Full Text] [Related]
23. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
[TBL] [Abstract][Full Text] [Related]
24. Novel lncRNA
Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
[TBL] [Abstract][Full Text] [Related]
25. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially.
Yu X; Gupta A; Wang Y; Suzuki K; Mirosevich J; Orgebin-Crist MC; Matusik RJ
Ann N Y Acad Sci; 2005 Dec; 1061():77-93. PubMed ID: 16467259
[TBL] [Abstract][Full Text] [Related]
26. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
[TBL] [Abstract][Full Text] [Related]
27. Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome.
Leach DA; Panagopoulos V; Nash C; Bevan C; Thomson AA; Selth LA; Buchanan G
Mol Cell Endocrinol; 2017 Jan; 439():261-272. PubMed ID: 27634452
[TBL] [Abstract][Full Text] [Related]
28. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
[TBL] [Abstract][Full Text] [Related]
29. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells.
Miyajima N; Maruyama S; Bohgaki M; Kano S; Shigemura M; Shinohara N; Nonomura K; Hatakeyama S
Cancer Res; 2008 May; 68(9):3486-94. PubMed ID: 18451177
[TBL] [Abstract][Full Text] [Related]
30. Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus.
Rytinki M; Kaikkonen S; Sutinen P; Paakinaho V; Rahkama V; Palvimo JJ
Mol Cell Biol; 2012 Oct; 32(20):4195-205. PubMed ID: 22890844
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor.
Guseva NV; Rokhlin OW; Bair TB; Glover RB; Cohen MB
Oncotarget; 2012 Feb; 3(2):183-94. PubMed ID: 22383394
[TBL] [Abstract][Full Text] [Related]
32. FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression.
Zhao JC; Fong KW; Jin HJ; Yang YA; Kim J; Yu J
Oncogene; 2016 Aug; 35(33):4335-44. PubMed ID: 26751772
[TBL] [Abstract][Full Text] [Related]
33. Global SUMOylation on active chromatin is an acute heat stress response restricting transcription.
Niskanen EA; Malinen M; Sutinen P; Toropainen S; Paakinaho V; Vihervaara A; Joutsen J; Kaikkonen MU; Sistonen L; Palvimo JJ
Genome Biol; 2015 Jul; 16(1):153. PubMed ID: 26259101
[TBL] [Abstract][Full Text] [Related]
34. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.
Urbanucci A; Sahu B; Seppälä J; Larjo A; Latonen LM; Waltering KK; Tammela TL; Vessella RL; Lähdesmäki H; Jänne OA; Visakorpi T
Oncogene; 2012 Apr; 31(17):2153-63. PubMed ID: 21909140
[TBL] [Abstract][Full Text] [Related]
36. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
[TBL] [Abstract][Full Text] [Related]
37. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
[TBL] [Abstract][Full Text] [Related]
39. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.
Tam KJ; Dalal K; Hsing M; Cheng CW; Khosravi S; Yenki P; Tse C; Peacock JW; Sharma A; Chiang YT; Wang Y; Cherkasov A; Rennie PS; Gleave ME; Ong CJ
Oncotarget; 2017 Feb; 8(6):9617-9633. PubMed ID: 28038451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]